Profusa (NVACW) Return on Capital Employed (2022 - 2026)
Profusa (NVACW) reported Return on Capital Employed of 113.3% for Q1 2026, up 7729.0% on a YoY basis from 1.45% in Q1 2025, and down 25.29% quarter-over-quarter from 151.65% in Q4 2025.
Profusa (NVACW) Return on Capital Employed (2022 - 2026) Analysis & Trends
Profusa has reported Return on Capital Employed for 5 years, with the latest figure at 113.3% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 7729.0% year-over-year to 113.3%; the trailing twelve-month figure through Mar 2026 stood at 113.3% (up 7729.0% YoY), and the FY2025 full-year result was 147.11%, up 13813.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 113.3%, down from 151.65% in the prior quarter.
- The five-year high for Return on Capital Employed was 151.65% in Q4 2025, with the low at 798.11% in Q3 2025.
- Historically, Return on Capital Employed has averaged 46.48% across 5 years, with a median of 10.01% in 2023.
- The largest YoY upside for Return on Capital Employed was 14597 bps in 2025 against a maximum downside of 73316 bps in 2025.
- Profusa's Return on Capital Employed stood at 0.66% in 2022, then sank by 3776 bps to 25.47% in 2023, then surged by 122 bps to 5.68% in 2024, then soared by 2569 bps to 151.65% in 2025, then dropped by 25 bps to 113.3% in 2026.
- The last three Return on Capital Employed figures came in at 113.3% (Q1 2026), 151.65% (Q4 2025), and 798.11% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Profusa | - | - | - | 113.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.30% |
| Dec 31, 2025 | 151.65% |
| Sep 30, 2025 | -798.11% |
| Jun 30, 2025 | 32.21% |
| Mar 31, 2025 | 36.01% |
| Dec 31, 2024 | 5.68% |
| Sep 30, 2024 | -64.95% |
| Jun 30, 2024 | -33.60% |
| Mar 31, 2024 | -26.81% |
| Dec 31, 2023 | -25.47% |
| Sep 30, 2023 | -18.54% |
| Jun 30, 2023 | -20.00% |
| Mar 31, 2023 | -1.47% |
| Dec 31, 2022 | -0.66% |